Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$24.86 - $35.02 $403,378 - $568,234
-16,226 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$22.3 - $36.02 $371,897 - $600,705
-16,677 Reduced 50.69%
16,226 $567,000
Q1 2021

May 06, 2021

SELL
$26.38 - $51.15 $114,119 - $221,274
-4,326 Reduced 11.62%
32,903 $1.1 Million
Q4 2020

Feb 09, 2021

SELL
$10.5 - $28.5 $493,048 - $1.34 Million
-46,957 Reduced 55.78%
37,229 $966,000
Q3 2020

Nov 09, 2020

BUY
$3.61 - $9.87 $235,068 - $642,694
65,116 Added 341.46%
84,186 $831,000
Q2 2020

Aug 04, 2020

BUY
$2.65 - $4.03 $50,535 - $76,852
19,070 New
19,070 $66,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $353M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.